13-valent pneumococcal conjugate vaccine + 7-valent pneumococcal conjugate vaccine + Pentavac
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Vaccines, Pneumococcal
Conditions
Vaccines, Pneumococcal
Trial Timeline
Oct 1, 2006 → Nov 1, 2008
NCT ID
NCT00366678About 13-valent pneumococcal conjugate vaccine + 7-valent pneumococcal conjugate vaccine + Pentavac
13-valent pneumococcal conjugate vaccine + 7-valent pneumococcal conjugate vaccine + Pentavac is a phase 3 stage product being developed by Pfizer for Vaccines, Pneumococcal. The current trial status is completed. This product is registered under clinical trial identifier NCT00366678. Target conditions include Vaccines, Pneumococcal.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00366678 | Phase 3 | Completed |
Competing Products
20 competing products in Vaccines, Pneumococcal